NEW YORK (Reuters Health) - The COX-2 inhibitor Celebrex, usually prescribed for arthritis, has a marked effect on the asbestos-related cancer malignant mesothelioma in lab and animal experiments, according to a report from Italy.
News Source: Reuters | Published: May 10, 2004 |
Read Full Story

